Safety and Efficacy of a MEURI Program for the Use of High Dose Ivermectin in COVID-19 Patients

• Main Authors: Marcos Alejandro Mayer (Author), Alejandro Krolewiecki (Author), Alejandro Ferrero (Author), Marcelo Bocchio (Author), Juan Barbero (Author), Marcos Miguel (Author), Ariel Paladini (Author), Carlos Delgado (Author), Juan Ramón Ojeda (Author), Claudia Elorza (Author), Ana Bertone (Author), Pedro Emanuel Fleitas (Author), Gustavo Vera (Author), Mario Rubén Kohan (Author)
• Formato: Libro
• Publicado: Frontiers Media S.A., 2022-02-01T00:00:00Z.
• Subjects: article
• Acceso en liña: Connect to this object online.

BackgroundIn the absence of antiviral alternatives, interventions under research for COVID-19 might be offered following guidelines from WHO for monitored emergency use of unregistered and experimental interventions (MEURI). Ivermectin is among several drugs explored for its role against SARS-CoV-2,...